![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
NEW YORK, NY / ACCESSWIRE / May 20, 2015 / Cell Source, Inc. (OTCQB: CLCS) a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine...
TEL AVIV, ISRAEL / ACCESSWIRE / March 9, 2015 / Cell Source, Inc. (OTCQB:CLCS) ("Cell Source") an immunotherapy and regenerative medicine company, announced today its President and CEO...
Cell Source's Megadose Drug Combination Receives Regulatory Approval in Italy to Commence Human Clinical Trials Independent, 3rd Party Researchers at Italian University to Conduct Study PR...
Cell Source to Present at the FireRock Conference and the Life Sciences Summit in New York City on October 28th and 29th, 2014 PR Newswire TEL AVIV, Israel, Oct. 8, 2014 TEL AVIV, Israel, Oct. 8...
Cell Source to Present at Rodman & Renshaw Global Investment Conference in New York City on September 10, 2014 PR Newswire TEL AVIV, Israel, Sept. 3, 2014 TEL AVIV, Israel, Sept. 3, 2014...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions